Epithalon vs Humanin
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Epitalon, Epithalone
Epithalon (also spelled Epitalon) is a synthetic four-amino-acid peptide, Ala-Glu-Asp-Gly (AEDG), modeled on a natural pineal gland extract. It came out of decades of Russian gerontology research led by Vladimir Khavinson and is marketed as an anti-aging compound that supposedly switches telomerase back on. It has no approval from the FDA, EMA, or other Western regulators, and the human evidence is thin.
Also: HN, HNG (S14G-humanin)
Humanin is a 24-amino-acid peptide encoded inside mitochondrial DNA (in the 16S rRNA gene), discovered in 2001 and named for its ability to protect human neurons from Alzheimer-related cell death. It was the first member of the mitochondrial-derived peptide family and is studied mainly for neuroprotection, cell survival, and metabolic and age-related disease. The honest status: it has the deepest preclinical evidence base of any mitochondrial peptide, but human therapeutic trials are essentially absent.
Key Comparison Insights
- Epithalon is categorized as Bioregulators, while Humanin is Anti-Aging.
- Epithalon has stronger research evidence (Human Trials) compared to Humanin (Animal Studies).
Detailed Comparison
| Attribute | Epithalon | Humanin |
|---|---|---|
| Category | Bioregulators | Anti-Aging |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | The headline claim is telomerase activation. Telomerase is the enzyme that rebuilds telomeres, the protective caps on chromosome ends that shorten as cells divide and age. In cell cultures, Epithalon appears to switch on telomerase in cells that normally lack it, allowing telomeres to lengthen. It is also proposed to influence melatonin production, antioxidant defenses, and gene expression in the pineal-hypothalamic axis. These are real findings in dishes and animals, but the leap from a telomerase signal in a petri dish to actually slowing human aging is a hypothesis, not a proven mechanism. | Humanin is fundamentally a cell-survival signal that blocks apoptosis, the programmed self-destruct cells run when stressed. It binds a trimeric receptor complex made of CNTFR, WSX-1, and gp130 on the cell surface, switching on JAK2/STAT3 survival signaling. Inside the cell it directly grabs the pro-apoptotic protein BAX and stops it from moving to the mitochondria and punching holes in the membrane, which is the step that would otherwise commit the cell to death. It also binds IGFBP-3, modulating IGF-1 signaling and further dialing down apoptosis, and it interacts with formyl peptide receptors. The throughline across all of these is the same: keep stressed cells alive and protect mitochondria. |
| Common Dosing | 5-10 mg daily for 10-20 days Once daily in cycles | 5-10 mg weekly divided into 2-3 injections 2-3x weekly (e.g., Monday, Wednesday, Friday) |
| Administration | Subcutaneous or intramuscular injection | Injection (route varies) |
| Typical Duration | 10-20 day cycles | Variable |
| Best Time to Take | Before bed | Morning |
Possible Side Effects May vary by individual |
|
|
| Research Summary | The cell-level evidence is the strongest part of the story. Khavinson and colleagues (Bulletin of Experimental Biology and Medicine, 2003) showed Epithalon induced telomerase activity and elongated telomeres in cultured human fibroblasts, and a 2025 review in the International Journal of Molecular Sciences summarized its geroprotective and neuroendocrine effects. Animal studies from the same Russian groups reported longer lifespan and reduced tumor incidence in mice and rats. The problem is the human side: replication outside those groups is limited to small, often open-label studies and case reports, with no large, independent, placebo-controlled trials proving it extends human lifespan or reliably lengthens telomeres in people. Its safety record in the published literature looks clean at research doses, but clean and unapproved are not the same as proven. So the honest read is promising preclinical data, real research lineage, and unproven human benefit. | Humanin is one of the best-characterized mitochondrial peptides in the lab, with a large body of in vitro and animal work. It protects neurons against amyloid-beta toxicity, shields retinal pigment epithelium cells from oxidative stress and senescence, and shows protective effects in models of cardiovascular disease and diabetes. Circulating humanin declines with age in humans, and some studies link higher endogenous levels to better metabolic and longevity markers, which fuels the longevity interest. But that is association and animal data, not proof that taking humanin treats any disease. There are no large completed randomized human trials demonstrating clinical benefit, and most of what is sold to consumers is synthetic humanin or analogues like HNG, used far ahead of the evidence. It is a compelling research molecule, not a validated drug. |
Frequently Asked Questions: Epithalon vs Humanin
What is the difference between Epithalon and Humanin?
Epithalon is a bioregulators peptide that epithalon (also spelled epitalon) is a synthetic four-amino-acid peptide, ala-glu-asp-gly (aedg), modeled on a natural pineal gland extract. it came out of decades of russian gerontology research led by vladimir khavinson and is marketed as an anti-aging compound that supposedly switches telomerase back on. it has no approval from the fda, ema, or other western regulators, and the human evidence is thin. Humanin is a anti-aging peptide that humanin is a 24-amino-acid peptide encoded inside mitochondrial dna (in the 16s rrna gene), discovered in 2001 and named for its ability to protect human neurons from alzheimer-related cell death. it was the first member of the mitochondrial-derived peptide family and is studied mainly for neuroprotection, cell survival, and metabolic and age-related disease. the honest status: it has the deepest preclinical evidence base of any mitochondrial peptide, but human therapeutic trials are essentially absent. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Epithalon or Humanin?
Neither is universally "better" - the choice depends on your specific goals. Epithalon is typically used for bioregulators purposes, while Humanin is used for anti-aging. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Epithalon and Humanin be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Epithalon and Humanin together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.